Immediate Impact
52 standout
Citing Papers
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Wei Lin being referenced
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer
2020
The predictive value of procalcitonin for early detection of infection in elderly type 2 diabetes mellitus
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Wei Lin | 75 | 126 | 251 | 169 | 160 | 99 | 942 | |
| Kristopher Kapphahn | 49 | 112 | 273 | 152 | 139 | 53 | 1.1k | |
| Hirotaka Ochiai | 138 | 95 | 374 | 102 | 140 | 71 | 955 | |
| Isabela M Benseñor | 75 | 122 | 219 | 152 | 139 | 89 | 1.1k | |
| Margo A. Sidell | 38 | 84 | 234 | 131 | 113 | 59 | 999 | |
| Maria Luiza Garcia Rosa | 37 | 57 | 402 | 148 | 196 | 86 | 1.0k | |
| Ángel Arturo López‐González | 66 | 305 | 257 | 136 | 216 | 119 | 1.1k | |
| John A. Linton | 122 | 212 | 227 | 73 | 167 | 53 | 1.1k | |
| Raha Pazoki | 167 | 114 | 243 | 211 | 185 | 38 | 1.2k | |
| Ana Luíza Lima Sousa | 28 | 69 | 220 | 216 | 97 | 94 | 1.0k | |
| Karlijn Meeks | 176 | 325 | 273 | 196 | 254 | 87 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...